Oncology Information Systems Market (2025-2032)

The Oncology Information Systems Market is projected to reach $4.45 billion by 2032, at a CAGR of 7.4% from 2025 to 2032.

Published
Jan 2025
Pages
180
Format
PDF + Excel
Report ID
MRHC - 104908
Base year
2024
Market size · USD billion · 2024–2032Forecast 2025–2032 · 7.4% CAGR
2032 · FORECAST
$4.45B
2032
$4.45B
CAGR 2025–2032
7.4%
$6B$4.5B$3B$1.5B0
2024
2025
'26
'27
'28
'29
'30
'31
'32

2024 baseline · 2025–2032 forecast at 7.4% CAGR · hover a bar for the value

Key highlights

01

In 2025, the Software Segment is Expected to Dominate the Oncology Information Systems Market

02

In 2025, the Medical Oncology Segment is Expected to Dominate the Oncology Information Systems Market

03

In 2025, the Hospitals Segment is Expected to Dominate the Oncology Information Systems Market

04

Asia-Pacific: The Fastest-growing Regional Market

Report summary

ParticularsDetails
Base Year2024
Estimated Year2025
Forecast Period2025–2032
Market Size (2032)USD 4.45 billion
CAGR (2025–2032)7.4%
FormatPDF, Excel & Cloud Portal · 180 pages
Segments CoveredBy Offering: Software Patient Information Systems, Treatment Planning Systems · By Application: Radiation Oncology, Medical Oncology, Surgical Oncology · By End User: Hospitals, Diagnostic Imaging Centers, Cancer Care Centers, Other End Users
Countries CoveredNorth America (Canada), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific)
Key CompaniesAccuray Incorporated (U.S.), Brainlab AG, DOSIsoft SA, Elekta AB, Koninklijke Philips N.V., MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories, Siemens Healthcare GmbH, McKesson Corporation (U.S.), Altai, Inc, ViewRay Inc. (U.S.)

Report overview

Scope note

Segments covered: offering, application, end user. Regions: North America, Europe, Asia-Pacific.

An oncology information system (OIS) is a software solution used to manage all aspects of cancer care, such as patient treatment schedules, treatment plans, treatment delivery, treatment summaries, and results. It differs from other types of information systems by its design and purpose, as it is specifically intended for managing cancer patients. It collects long-term patient data from patient history to various phases of treatments, diagnostic imaging, palliative care, and end-of-life care.

The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, rising need to reduce oncology care costs, increasing adoption of electronic health records (EHR), and increased demand for streamlined patient information and data management. In addition, the integration of precision medicine for cancer treatment and its potential in emerging countries are expected to provide significant growth opportunities for this market.

However, the high cost of oncology information systems and data security and privacy concerns are expected to restrain the growth of this market to a certain extent. In addition, factors such as barriers to adoption and implementation and additional requirement for training and education for using oncology information systems pose major challenges to the market’s growth.

Cancer has been one of the most complex and expensive diseases globally, with a huge economic burden on many countries. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetimes, with 1 in 8 men and 1 in 11 women dying from the disease.

Cancer is a major cause of death and a prominent obstacle to improving life expectancy in every country worldwide. According to the International Agency for Research on Cancer (IARC), the number of new cancer cases is expected to increase from 19.2 million in 2020 to 24.5 million by 2032. In addition, mortalities from cancer are expected to increase from 9.9 million in 2020 to 12.9 million by 2032.

Early disease diagnosis and effective treatment can help decrease cancer mortality rates. As cancer treatment takes a long time, providing effective treatment can be improved by optimizing data collection and analysis. Oncology information systems support cancer care by collecting patient data during various stages of cancer care, including screening, prevention, diagnosis, treatment, palliative care, and end-of-life care. It helps streamline patient data and supports clinical decision-making. The rising prevalence of cancer is expected to drive the demand for oncology information systems.

The diagnosis, medication, and treatment for cancer is very costly since it requires treatment through surgery, radiotherapy, and chemotherapy. Owing to the high cost of cancer treatment, it causes an economic burden on countries. According to a study published in the JAMA Oncology journal, the global economic cost of cancers from 2020 to 2050 was estimated to be USD 25.2 trillion. The U.S. and China are estimated to face the largest economic burden of cancer. Hence, there is a rising need to reduce oncology care costs.

Oncology information systems can improve cancer care by improving documentation, optimizing resource allocation, and increasing cancer care's cost-effectiveness. Various professionals are involved in the care, such as oncologists, pathologists, radiologists, pharmacists, and laboratory technicians. Due to this, the adoption of oncology information systems reduces errors and increases data accuracy & efficiency through automating activities.

Thus, the rising need to reduce oncology care costs is expected to drive the demand for high adoption of oncology information systems in the coming years.

Report infographic

Oncology Information Systems Market
Oncology Information Systems Market · Report infographic

Table of contents

11 chapters · 90 sections · 180 pages · click to expand
Review the full research scope before you buy. Chapters can also be purchased individually.

1.1Market Definition & Scope
1.2Market Ecosystem
1.3Currency and Limitations
1.4Key Stakeholders

Segmental analysis

SegmentLargest share (2025)Fastest growth (2025–2032)
By OfferingSoftware—
By ApplicationMedical Oncology—
By End UserHospitals—
01

By Offering

  • The software segment is expected to account for the largest share of the oncology information systems market.
  • The large share of this segment is attributed to the factors such as the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.
CoversSoftware Patient Information SystemsTreatment Planning Systems
02

By Application

  • The medical oncology segment is expected to account for the largest share of the oncology information systems market.
  • The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.
CoversRadiation OncologyMedical OncologySurgical Oncology
03

By End User

  • The hospitals segment is expected to account for the largest share of the oncology information systems market.
  • The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement an oncology information system, and increased number of cancer patients.
CoversHospitalsDiagnostic Imaging CentersCancer Care CentersOther End Users

Geographic analysis

01

Asia-Pacific

Fastest growth
China, Japan, India, Rest of Asia-Pacific

Asia-Pacific is slated to record the highest CAGR in the oncology information systems market during the forecast period. The growth of this regional market is driven by the increasing number of oncology specialty hospitals, increasing awareness about health information systems (HIS), and increasing volume of patient data in the region. Asia-Pacific: The Fastest-growing Regional Market

Competitive landscape

Companies profiled (13)
  • Accuray Incorporated (U.S.)
  • Brainlab AG · Germany
  • DOSIsoft SA · France
  • Elekta AB · Sweden
  • Koninklijke Philips N.V. · Netherlands
  • MIM Software Inc. (U.S.)
  • Oracle Corporation (U.S.)
  • Prowess Inc. (U.S.)
  • RaySearch Laboratories · Sweden
  • Siemens Healthcare GmbH · Germany
  • McKesson Corporation (U.S.)
  • Altai, Inc · Turkey
  • ViewRay Inc. (U.S.)

Frequently asked questions

This market study covers the market sizes & forecasts of the oncology information systems market based on offerings, application, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the oncology information systems market at the regional and country levels.

Cite this report

Meticulous Research. (2025). Oncology Information Systems Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 104908). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/oncology-information-systems-market-5591

Search Market Intelligence

Search across reports, blogs, press releases, and industries